Integrated Filing — IndAS
General information about company
| Scrip Code |
539148 |
| NSE Symbol |
SHIVALIK |
| MSEI Symbol |
NA |
| ISIN |
INE788J01021 |
| Name of company |
Shivalik Rasayan Limited |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
27-05-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
20-05-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Fourth quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Audited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
27-05-2026 15:30:00 |
| End date and time of board meeting |
27-05-2026 16:40:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
10,281.57 |
36,800.32 |
|
Other income |
191.64 |
407.77 |
|
Total income |
10,473.21 |
37,208.09 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
4,917.33 |
19,699.33 |
| (b) |
Purchases of stock-in-trade |
0.00 |
0.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
633.66 |
(861.89) |
| (d) |
Employee benefit expense |
1,564.32 |
6,055.47 |
| (e) |
Finance costs |
245.70 |
960.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
415.88 |
1,876.67 |
| (f) |
Other Expenses |
| 1 |
Other Expenses |
1,923.69 |
7,330.94 |
|
Total other expenses |
1,923.69 |
7,330.94 |
|
Total expenses |
9,700.58 |
35,060.52 |
| 3 |
Total profit before exceptional items and tax |
772.63 |
2,147.57 |
| 4 |
Exceptional items |
0.00 |
0.00 |
| 5 |
Total profit before tax |
772.63 |
2,147.57 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
3.52 |
457.10 |
| 8 |
Deferred tax |
51.79 |
(106.41) |
| 9 |
Total tax expenses |
55.31 |
350.69 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
717.32 |
1,796.88 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
0.00 |
0.00 |
| 16 |
Total profit (loss) for period |
717.32 |
1,796.88 |
| 17 |
Other comprehensive income net of taxes |
0.00 |
0.00 |
| 18 |
Total Comprehensive Income for the period |
717.32 |
1,796.88 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
452.54 |
1,213.60 |
|
Total profit or loss, attributable to non-controlling interests |
264.77 |
583.27 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
0.00 |
0.00 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
0.00 |
0.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
787.52 |
787.52 |
|
Face value of equity share capital |
5 |
5 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
0.00 |
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
2.87 |
7.71 |
|
Diluted earnings (loss) per share from continuing operations |
2.87 |
7.71 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
2.87 |
7.71 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
2.87 |
7.71 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2025 |
| Date of end of reporting period |
31-03-2026 |
| Whether results are audited or unaudited |
Audited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
33,399.84 |
|
Capital work-in-progress |
|
|
Investment property |
|
|
Goodwill |
0.00 |
|
Other intangible assets |
57.16 |
|
Intangible assets under development |
|
|
Biological assets other than bearer plants |
|
|
Investments accounted for using equity method |
|
|
Non-current financial assets |
|
|
Non-current investments |
0.00 |
|
Trade receivables, non-current |
|
|
Loans, non-current |
624.85 |
|
Other non-current financial assets |
|
|
Total of other non-current financial assets |
|
|
Total non-current financial assets |
624.85 |
|
Deferred tax assets (net) |
723.50 |
|
Other non-current assets |
|
| 1 |
Other non-current assets |
8,873.15 |
|
Total of other non-current assets |
8,873.15 |
|
Total non-current assets |
43,678.50 |
| 2 |
Current assets |
|
|
Inventories |
14,687.43 |
|
Current financial asset |
|
|
Current investments |
0.00 |
|
Trade receivables, current |
11,514.03 |
|
Cash and cash equivalents |
3,436.78 |
|
Bank balance other than cash and cash equivalents |
0.00 |
|
Loans, current |
397.30 |
|
Other current financial assets |
|
|
Total of other current financial assets |
|
|
Total current financial assets |
15,348.11 |
|
Current tax assets (net) |
|
|
Other current assets |
|
| 1 |
Other current assets |
8,172.84 |
|
Total of other current assets |
8,172.84 |
|
Total current assets |
38,208.38 |
| 3 |
Non-current assets classified as held for sale |
|
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
|
|
Total assets |
81,886.88 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
787.52 |
|
Other equity |
59,122.95 |
|
Total equity attributable to owners of parent |
59,910.47 |
|
Non controlling interest |
|
|
Total equity |
59,910.47 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
2,617.90 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
|
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
|
|
Total Trade payable |
|
|
Other non-current financial liabilities |
|
|
Total of other non-current financial liabilities |
|
|
Total non-current financial liabilities |
2,617.90 |
|
Provisions, non-current |
340.30 |
|
Deferred tax liabilities (net) |
|
|
Deferred government grants, Non-current |
|
|
Other non-current liabilities |
|
|
Total of other non-current liabilities |
|
|
Total non-current liabilities |
2,958.20 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
8,746.39 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
136.19 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
7,853.25 |
|
Total Trade payable |
7,989.44 |
|
Other current financial liabilities |
|
|
Total of other current financial liabilities |
|
|
Total current financial liabilities |
16,735.83 |
|
Other current liabilities |
1,443.49 |
| 1 |
Other current liabilities |
1,443.49 |
|
Total of other current liabilities |
1,443.49 |
|
Provisions, current |
378.08 |
|
Current tax liabilities (Net) |
460.81 |
|
Deferred government grants, Current |
|
|
Total current liabilities |
19,018.21 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
|
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
|
|
Total liabilities |
21,976.41 |
|
Total equity and liabilites |
81,886.88 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| Date of end of reporting
period |
31-03-2026 |
31-03-2026 |
| Whether results are audited
or unaudited |
Audited |
Audited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
Agrochemicals |
3,443.76 |
15,125.67 |
| 2 |
Active Pharma Ingredient (API) |
0.0047442 |
0.0090479 |
| 3 |
Pharma Formulation |
6,064.66 |
19,776.97 |
| 4 |
Unallacated other operating revenue |
0.0029873 |
0.0099289 |
|
Total Segment Revenue |
10,281.57 |
36,800.32 |
|
Less: Inter segment revenue |
0.00 |
0.00 |
|
Revenue from operations |
10,281.57 |
36,800.32 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
Agrochemicals |
268.22 |
2,202.11 |
| 2 |
Active Pharma Ingredient (API) |
205.85 |
(642.72) |
| 3 |
Pharma Formulation |
544.27 |
1,548.17 |
| 4 |
Unallacated other operating revenue |
0.00 |
0.00 |
|
Total Profit before tax |
1,018.34 |
3,107.56 |
|
i. Finance cost |
245.70 |
960.00 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
0.00 |
0.00 |
|
Profit before tax |
772.64 |
2,147.56 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
Agrochemicals |
31,712.12 |
31,712.12 |
| 2 |
Active Pharma Ingredient (API) |
12,569.22 |
12,569.22 |
| 3 |
Pharma Formulation |
35,608.64 |
35,608.64 |
| 4 |
Unallacated other operating revenue |
0.00 |
0.00 |
|
Total Segment Asset |
79,889.98 |
79,889.98 |
|
Un-allocable Assets |
0.00 |
0.00 |
|
Net Segment Asset |
79,889.98 |
79,889.98 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
Agrochemicals |
5,978.09 |
5,978.09 |
| 2 |
Active Pharma Ingredient (API) |
1,209.77 |
1,209.77 |
| 3 |
Pharma Formulation |
4,846.77 |
4,846.77 |
| 4 |
Unallacated other operating revenue |
0.00 |
0.00 |
|
Total Segment Liabilities |
12,034.63 |
12,034.63 |
|
Un-allocable Liabilities |
0.00 |
0.00 |
|
Net Segment Liabilities |
12,034.63 |
12,034.63 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
|
Total Amount of items that will not be reclassified to profit and loss |
|
|
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
|
|
| 3 |
Amount of items that will be reclassified to profit and loss |
|
|
Total Amount of items that will be reclassified to profit and loss |
|
|
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
|
|
| 5 |
Total Other comprehensive income |
|
|
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
2,147.57 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
960.00 |
|
Adjustments for decrease (increase) in inventories |
(2,943.68) |
|
Adjustments for decrease (increase) in trade receivables, current |
(1,902.44) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
(942.90) |
|
Adjustments for decrease (increase) in other non-current assets |
(2,182.69) |
|
Adjustments for other financial assets, non-current |
0.00 |
|
Adjustments for other financial assets, current |
0.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
1,358.45 |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
(1,411.36) |
|
Adjustments for increase (decrease) in other non-current liabilities
|
137.12 |
|
Adjustments for depreciation and amortisation expense |
1,876.66 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
0.00 |
|
Adjustments for provisions, current |
0.00 |
|
Adjustments for provisions, non-current |
0.00 |
|
Adjustments for other financial liabilities, current |
0.00 |
|
Adjustments for other financial liabilities, non-current |
0.00 |
|
Adjustments for unrealised foreign exchange losses gains |
0.00 |
|
Adjustments for dividend income |
0.00 |
|
Adjustments for interest income |
209.14 |
|
Adjustments for share-based payments |
0.00 |
|
Adjustments for fair value losses (gains) |
0.00 |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
0.00 |
|
Other adjustments to reconcile profit (loss) |
0.00 |
|
Other adjustments for non-cash items |
0.00 |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
(5,259.98) |
|
Net cash flows from (used in)
operations |
(3,112.41) |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
283.50 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
(3,395.91) |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
0.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
0.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
0.00 |
|
Purchase of property, plant and equipment |
2,331.81 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
0.00 |
|
Interest received |
209.15 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
investing activities |
(2,122.66) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
84.82 |
|
Proceeds from issuing other equity instruments |
5,271.97 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
1,975.99 |
|
Repayments of borrowings |
0.00 |
|
Payments of lease liabilities |
0.00 |
|
Dividends paid |
214.39 |
|
Interest paid |
0.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
(960.00) |
|
Net cash flows from (used in)
financing activities |
6,158.39 |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
639.82 |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
0.00 |
|
Net increase (decrease) in cash
and cash equivalents |
639.82 |
|
Cash and cash equivalents cash flow statement at beginning of period
|
2,796.96 |
|
Cash and cash equivalents cash
flow statement at end of period |
3,436.78 |
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
M/s Rahul Chaudhary & Associates, Chartered Accountants |
Yes |
30-09-2026 |